Artiva Biotherapeutics, Inc. Common Stock (ARTV) Ownership

$2.18

$0.14 (6.86%)
Last update: 04:00 PM EST
Day's range
$2.05
Day's range
$2.18

Artiva Biotherapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 9.85 M $29.56 M   0.00% 40.48%
5AM VENTURE MANAGEMENT, LLC 05/15/2025 2.35 M $7.06 M   0.00% 9.67%
VR ADVISER, LLC 05/15/2025 1.61 M $4.83 M   0.00% 6.61%
BLACKROCK, INC. 05/02/2025 1.25 M $3.74 M   19.03% 5.12%
VENBIO PARTNERS LLC 05/15/2025 1.20 M $3.60 M   -21.12% 4.93%
CAPITAL WORLD INVESTORS 05/12/2025 866.62 K $2.60 M   -5.33% 3.56%
VANGUARD GROUP INC 05/09/2025 858.21 K $2.57 M   -1.00% 3.53%
FRANKLIN RESOURCES INC 05/13/2025 520.33 K $1.56 M   0.01% 2.14%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 410.46 K $1.23 M   29.99% 1.69%
SAMSARA BIOCAPITAL, LLC 05/15/2025 291.67 K $875.00 K   0.00% 1.20%
WOODLINE PARTNERS LP 05/15/2025 283.12 K $849.37 K   0.00% 1.16%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 194.11 K $582.32 K   0.00% 0.80%
STATE STREET CORP 05/15/2025 171.78 K $515.35 K   4.25% 0.71%
CITADEL ADVISORS LLC 05/15/2025 145.09 K $435.27 K   40.00% 0.60%
LOGOS GLOBAL MANAGEMENT LP 05/15/2025 145.09 K $435.27 K   0.00% 0.60%
NORTHERN TRUST CORP 05/13/2025 141.68 K $425.03 K   20.97% 0.58%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2025 100.00 K $300.00 K   0.00% 0.41%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 54.88 K $164.64 K   26.09% 0.23%
05/12/2025 47.89 K $143.68 K   100.00% 0.20%
ACUTA CAPITAL PARTNERS, LLC 05/15/2025 45.46 K $136.37 K   3.31% 0.19%
UBS GROUP AG 05/13/2025 43.08 K $129.23 K   21.76% 0.18%
GOLDMAN SACHS GROUP INC 06/27/2025 41.95 K $125.86 K   10.20% 0.17%
BANK OF NEW YORK MELLON CORP 04/29/2025 33.31 K $99.92 K   0.00% 0.14%
SEI INVESTMENTS CO 05/14/2025 29.28 K $87.84 K   100.00% 0.12%
MORGAN STANLEY 05/15/2025 27.82 K $83.46 K   -25.39% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 24.36 K $73.07 K   100.00% 0.10%
BARCLAYS PLC 05/15/2025 22.75 K $68.00 K   -5.83% 0.09%
DEUTSCHE BANK AG\ 05/09/2025 21.42 K $64.27 K   0.00% 0.09%
JPMORGAN CHASE & CO 05/12/2025 17.88 K $53.65 K   -52.46% 0.07%
RHUMBLINE ADVISERS 05/29/2025 14.49 K $43.48 K   12.53% 0.06%
CITIGROUP INC 05/12/2025 14.34 K $43.01 K   -8.13% 0.06%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 13.23 K $39.69 K   33.92% 0.05%
WELLS FARGO & COMPANY/MN 05/13/2025 12.66 K $37.98 K   46.92% 0.05%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 11.55 K $34.64 K   100.00% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 11.48 K $34.43 K   42.77% 0.05%
COREBRIDGE FINANCIAL, INC. 05/14/2025 9.74 K $29.21 K   33.60% 0.04%
BANK OF AMERICA CORP /DE/ 05/15/2025 8.30 K $24.89 K   -23.31% 0.03%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 04/30/2025 4.87 K $14.62 K   -5.40% 0.02%
FMR LLC 05/12/2025 3.56 K $10.67 K   295.00% 0.01%
05/09/2025 3.48 K $10.43 K   0.00% 0.01%
NEW YORK STATE COMMON RETIREMENT FUND 05/01/2025 2.94 K $9.00 K   0.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 2.61 K $7.84 K   115.68% 0.01%
LEGAL & GENERAL GROUP PLC 05/15/2025 2.02 K $6.05 K   44.87% 0.01%
AMERITAS INVESTMENT PARTNERS, INC. 05/12/2025 1.42 K $4.27 K   0.00% 0.01%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 05/15/2025 1.04 K $3.12 K   0.00% 0.00%
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. 04/24/2025 813 $2.57 K   0.49% 0.00%
04/29/2025 603 $1.81 K   18.24% 0.00%
AMALGAMATED BANK 04/25/2025 480 $1.00 K   0.00% 0.00%
ROYAL BANK OF CANADA 05/15/2025 478 $1.00 K   -56.78% 0.00%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 05/13/2025 400 $1.20 K   -55.56% 0.00%

Artiva Biotherapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 58 institutional investors and hedge funds held shares of Artiva Biotherapeutics, Inc.. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 9.85 M

5AM Venture Management, LLC: 2.35 M

VR Adviser, LLC: 1.61 M

BlackRock, Inc.: 1.25 M

venBio Partners LLC: 1.2 M

Capital World Investors: 866,622

85.94% of Artiva Biotherapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 20.92 M shares in the last 24 months. This purchase volume represents approximately $45.18 M in transactions.